Cite
MLA Citation
L. Bergmann et al.. “2617 A Prospective Randomized Phase-II Trial with Temsirolimus vs. Sunitinib in non-clear Renal Cell Carcinoma. A Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and Interdisciplinary Renal Cell Carcinoma Group of the German Cancer Society (IAGN).” European journal of cancer, vol. 51, n.d., pp. S517–. http://access.bl.uk/ark:/81055/vdc_100030628262.0x000018